市場調査レポート

商品コード

1285860

C反応性タンパク質検査市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

C-reactive Protein Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2023年04月30日 | 発行: Transparency Market Research

| ページ情報: 英文 194 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 908,424円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,378,704円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,848,984円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

C反応性タンパク質検査市場- レポートの範囲

TMRの調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も掲載しています。

当レポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

当レポートは、世界市場における競合情勢を詳しく掘り下げています。世界市場で活動している主要企業を特定し、さまざまな属性の観点からプロファイルしています。当レポートで紹介されている市場企業の属性は、会社概要、財務状況、最近の動向、SWOTです。

市場企業-競合マトリックス（企業の階層および規模別）
市場シェア分析：企業別（2022年）
企業プロファイル
- Agilent Technologies, Inc.
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Creative Diagnostics
- DxGen Corp
- CTK Biotech, Inc.
- Getein Biotech, Inc.
- Goldsite Diagnostics, Inc.
- OptiBio Co., Ltd.
- Nanjing Vazyme Biotech Co., Ltd.

図表

List of Tables

Table 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 02: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
Table 03: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 04: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 08: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
Table 09: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 10: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 13: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
Table 14: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 15: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 18: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
Table 19: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 20: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 23: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
Table 24: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 25: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 28: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
Table 29: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 30: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global C-reactive Protein Testing Market Value Share, by Test Type, 2022
Figure 03: Global C-reactive Protein Testing Market Value Share, by Types of Assay, 2022
Figure 04: Global C-reactive Protein Testing Market Value Share, by Indication, 2022
Figure 05: Global C-reactive Protein Testing Market Value Share, by End-user, 2022
Figure 06: Global C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 07: Global C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
Figure 08: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Standard C-reactive Protein Test , 2017-2031
Figure 09: Global C-reactive Protein Testing Market Revenue (US$ Mn), by High-sensitivity C-reactive Protein (hs-CRP) Test, 2017-2031
Figure 10: Global C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
Figure 11: Global C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
Figure 12: Global C-reactive Protein Testing Market Value (US$ Mn), by ELISA, 2017-2031
Figure 13: Global C-reactive Protein Testing Market Value (US$ Mn), by Immunoturbidimetry, 2017-2031
Figure 14: Global C-reactive Protein Testing Market Value (US$ Mn), by Irreversible Immuno-chromatography, 2017-2031
Figure 15: Global C-reactive Protein Testing Market Value (US$ Mn), by Immunofluorescence, 2017-2031
Figure 16: Global C-reactive Protein Testing Market Value (US$ Mn), by Others, 2017-2031
Figure 17: Global C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
Figure 18: Global C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
Figure 19: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Heart Diseases, 2017-2031
Figure 20: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Inflammatory Diseases, 2017-2031
Figure 21: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Infectious Diseases, 2017-2031
Figure 22: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Others, 2017-2031
Figure 23: Global C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: Global C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 25: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Hospital Associated Laboratories, 2017-2031
Figure 26: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Independent Diagnostic Laboratories, 2017-2031
Figure 27: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Others, 2017-2031
Figure 28: Global C-reactive Protein Testing Market Value Share Analysis, by Region, 2022 and 2031
Figure 29: Global C-reactive Protein Testing Market Attractiveness Analysis, by Region, 2023-2031
Figure 30: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 31: North America C-reactive Protein Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 32: North America C-reactive Protein Testing Market Attractiveness Analysis, by Country, 2023-2031
Figure 33: North America C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 34: North America C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
Figure 35: North America C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
Figure 36: North America C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
Figure 37: North America C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
Figure 38: North America C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
Figure 39: North America C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: North America C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 41: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 42: Europe C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 43: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 44: Europe C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 45: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
Figure 46: Europe C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
Figure 47: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
Figure 48: Europe C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
Figure 49: Europe C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
Figure 50: Europe C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Europe C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 52: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 53: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 54: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 55: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 56: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
Figure 57: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
Figure 58: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
Figure 59: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
Figure 60: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
Figure 61: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 63: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 64: Latin America C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 65: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 66: Latin America C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 67: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
Figure 68: Latin America C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
Figure 69: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
Figure 70: Latin America C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
Figure 71: Latin America C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
Figure 72: Latin America C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 74: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 75: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 76: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 77: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 78: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
Figure 79: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
Figure 80: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay 2023-2031
Figure 81: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
Figure 82: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Indication, 2023-2031
Figure 83: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 84: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 85: Global C-reactive Protein Testing Market Share Analysis By Company (2022)

Product Code: TMRGL1899

C-Reactive Protein Testing Market - Scope of Report

TMR's report on the global C-Reactive Protein Testing Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global C-Reactive Protein Testing Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global C-Reactive Protein Testing Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the C-Reactive Protein Testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global C-Reactive Protein Testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global C-Reactive Protein Testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global C-Reactive Protein Testing market.

The report delves into the competitive landscape of the global C-Reactive Protein Testing market. Key players operating in the global C-Reactive Protein Testing Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global C-Reactive Protein Testing Market profiled in this report.

Key Questions Answered in Global C-Reactive Protein Testing Market Report:

What is the sales/revenue generated by C-Reactive Protein Testing across all regions during the forecast period?
What are the opportunities in the global C-Reactive Protein Testing market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

C-Reactive Protein Testing Market - Research Objectives and Research Approach

The comprehensive report on the global C-Reactive Protein Testing Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global C-Reactive Protein Testing Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global C-Reactive Protein Testing market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global C-reactive Protein Testing Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global C-reactive Protein Testing Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Overview of C-reactive Protein Testing Market
5.2. Key Product/ Brand Analysis
5.3. Pipeline Analysis
5.4. COVID-19 Pandemic Impact on Industry

6. Global C-reactive Protein Testing Market Analysis and Forecast, by Test Type

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2017-2031
- 6.3.1. Standard C-reactive Protein Test
- 6.3.2. High-sensitivity C-reactive Protein (hs-CRP) Test
6.4. Market Attractiveness Analysis, by Test Type

7. Global C-reactive Protein Testing Market Analysis and Forecast, by Type of Assay

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type of Assay, 2017-2031
- 7.3.1. ELISA
- 7.3.2. Immunoturbidimetry
- 7.3.3. Immuno-chromatography
- 7.3.4. Immunofluorescence
- 7.3.5. Others
7.4. Market Attractiveness Analysis, by Type of Assay

8. Global C-reactive Protein Testing Market Analysis and Forecasts, by Indication

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2017-2031
- 8.3.1. Heart Diseases
- 8.3.2. Inflammatory Diseases
- 8.3.3. Infectious Diseases
- 8.3.4. Others
8.4. Market Attractiveness Analysis, by Indication

9. Global C-reactive Protein Testing Market Analysis and Forecast, by End-user

9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospital Associated Laboratories
- 9.3.2. Independent Diagnostic Laboratories
- 9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user

10. Global C-reactive Protein Testing Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region

11. North America C-reactive Protein Testing Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017-2031
- 11.2.1. Standard C-reactive Protein Test
- 11.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
11.3. Market Value Forecast, by Type of Assay, 2017-2031
- 11.3.1. ELISA
- 11.3.2. Immunoturbidimetry
- 11.3.3. Immuno-chromatography
- 11.3.4. Immunofluorescence
- 11.3.5. Others
11.4. Market Value Forecast, by Indication, 2017-2031
- 11.4.1. Heart Diseases
- 11.4.2. Inflammatory Diseases
- 11.4.3. Infectious Diseases
- 11.4.4. Others
11.5. Market Value Forecast, by End-user, 2017-2031
- 11.5.1. Hospital Associated Laboratories
- 11.5.2. Independent Diagnostic Laboratories
- 11.5.3. Others
11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Test Type
- 11.7.2. By Type of Assay
- 11.7.3. By Indication
- 11.7.4. By End-user
- 11.7.5. By Country

12. Europe C-reactive Protein Testing Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017-2031
- 12.2.1. Standard C-reactive Protein Test
- 12.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
12.3. Market Value Forecast, by Type of Assay, 2017-2031
- 12.3.1. ELISA
- 12.3.2. Immunoturbidimetry
- 12.3.3. Immuno-chromatography
- 12.3.4. Immunofluorescence
- 12.3.5. Others
12.4. Market Value Forecast, by Indication, 2017-2031
- 12.4.1. Heart Diseases
- 12.4.2. Inflammatory Diseases
- 12.4.3. Infectious Diseases
- 12.4.4. Others
12.5. Market Value Forecast, by End-user, 2017-2031
- 12.5.1. Hospital Associated Laboratories
- 12.5.2. Independent Diagnostic Laboratories
- 12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. By Test Type
- 12.7.2. By Type of Assay
- 12.7.3. By Indication
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region

13. Asia Pacific C-reactive Protein Testing Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017-2031
- 13.2.1. Standard C-reactive Protein Test
- 13.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
13.3. Market Value Forecast, by Type of Assay, 2017-2031
- 13.3.1. ELISA
- 13.3.2. Immunoturbidimetry
- 13.3.3. Immuno-chromatography
- 13.3.4. Immunofluorescence
- 13.3.5. Others
13.4. Market Value Forecast, by Indication, 2017-2031
- 13.4.1. Heart Diseases
- 13.4.2. Inflammatory Diseases
- 13.4.3. Infectious Diseases
- 13.4.4. Others
13.5. Market Value Forecast, by End-user, 2017-2031
- 13.5.1. Hospital Associated Laboratories
- 13.5.2. Independent Diagnostic Laboratories
- 13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. By Test Type
- 13.7.2. By Type of Assay
- 13.7.3. By Indication
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region

14. Latin America C-reactive Protein Testing Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Test Type, 2017-2031
- 14.2.1. Standard C-reactive Protein Test
- 14.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
14.3. Market Value Forecast, by Type of Assay, 2017-2031
- 14.3.1. ELISA
- 14.3.2. Immunoturbidimetry
- 14.3.3. Immuno-chromatography
- 14.3.4. Immunofluorescence
- 14.3.5. Others
14.4. Market Value Forecast, by Indication, 2017-2031
- 14.4.1. Heart Diseases
- 14.4.2. Inflammatory Diseases
- 14.4.3. Infectious Diseases
- 14.4.4. Others
14.5. Market Value Forecast, by End-user, 2017-2031
- 14.5.1. Hospital Associated Laboratories
- 14.5.2. Independent Diagnostic Laboratories
- 14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. By Test Type
- 14.7.2. By Type of Assay
- 14.7.3. By Indication
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region

15. Middle East & Africa C-reactive Protein Testing Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Test Type, 2017-2031
- 15.2.1. Standard C-reactive Protein Test
- 15.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
15.3. Market Value Forecast, by Type of Assay, 2017-2031
- 15.3.1. ELISA
- 15.3.2. Immunoturbidimetry
- 15.3.3. Immuno-chromatography
- 15.3.4. Immunofluorescence
- 15.3.5. Others
15.4. Market Value Forecast, by Indication, 2017-2031
- 15.4.1. Heart Diseases
- 15.4.2. Inflammatory Diseases
- 15.4.3. Infectious Diseases
- 15.4.4. Others
15.5. Market Value Forecast, by End-user, 2017-2031
- 15.5.1. Hospital Associated Laboratories
- 15.5.2. Independent Diagnostic Laboratories
- 15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. By Test Type
- 15.7.2. By Type of Assay
- 15.7.3. By Indication
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
- 16.3.1. Agilent Technologies, Inc.
  - 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.1.2. Product Portfolio
  - 16.3.1.3. Financial Overview
  - 16.3.1.4. SWOT Analysis
  - 16.3.1.5. Strategic Overview
- 16.3.2. Laboratory Corporation of America Holdings
  - 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.2.2. Product Portfolio
  - 16.3.2.3. Financial Overview
  - 16.3.2.4. SWOT Analysis
  - 16.3.2.5. Strategic Overview
- 16.3.3. Thermo Fisher Scientific
  - 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.3.2. Product Portfolio
  - 16.3.3.3. Financial Overview
  - 16.3.3.4. SWOT Analysis
  - 16.3.3.5. Strategic Overview
- 16.3.4. Abbott Laboratories
  - 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.4.2. Product Portfolio
  - 16.3.4.3. Financial Overview
  - 16.3.4.4. SWOT Analysis
  - 16.3.4.5. Strategic Overview
- 16.3.5. F. Hoffmann-La Roche Ltd.
  - 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.5.2. Product Portfolio
  - 16.3.5.3. Financial Overview
  - 16.3.5.4. SWOT Analysis
  - 16.3.5.5. Strategic Overview
- 16.3.6. Creative Diagnostics
  - 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.6.2. Product Portfolio
  - 16.3.6.3. Financial Overview
  - 16.3.6.4. SWOT Analysis
  - 16.3.6.5. Strategic Overview
- 16.3.7. DxGen Corp
  - 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.7.2. Product Portfolio
  - 16.3.7.3. Financial Overview
  - 16.3.7.4. SWOT Analysis
  - 16.3.7.5. Strategic Overview
- 16.3.8. CTK Biotech, Inc.
  - 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.8.2. Product Portfolio
  - 16.3.8.3. Financial Overview
  - 16.3.8.4. SWOT Analysis
  - 16.3.8.5. Strategic Overview
- 16.3.9. Getein Biotech, Inc.
  - 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.9.2. Product Portfolio
  - 16.3.9.3. Financial Overview
  - 16.3.9.4. SWOT Analysis
  - 16.3.9.5. Strategic Overview
- 16.3.10. Goldsite Diagnostics, Inc.
  - 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.10.2. Product Portfolio
  - 16.3.10.3. Financial Overview
  - 16.3.10.4. SWOT Analysis
  - 16.3.10.5. Strategic Overview
- 16.3.11. OptiBio Co., Ltd.
  - 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.11.2. Product Portfolio
  - 16.3.11.3. Financial Overview
  - 16.3.11.4. SWOT Analysis
  - 16.3.11.5. Strategic Overview
- 16.3.12. Nanjing Vazyme Biotech Co., Ltd.
  - 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.12.2. Product Portfolio
  - 16.3.12.3. Financial Overview
  - 16.3.12.4. SWOT Analysis
  - 16.3.12.5. Strategic Overview

C反応性タンパク質検査市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

C-reactive Protein Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

C反応性タンパク質検査市場- レポートの範囲

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

第5章 重要な洞察

第6章 世界市場の分析と予測：検査タイプ別

第7章 世界市場の分析と予測：アッセイタイプ別

第8章 世界市場の分析と予測：指標別

第9章 世界市場の分析と予測：エンドユーザー別

第10章 世界市場の分析と予測：地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

List of Tables

List of Figures

C-Reactive Protein Testing Market - Scope of Report

Key Questions Answered in Global C-Reactive Protein Testing Market Report:

C-Reactive Protein Testing Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global C-reactive Protein Testing Market

4. Market Overview

5. Key Insights

6. Global C-reactive Protein Testing Market Analysis and Forecast, by Test Type

7. Global C-reactive Protein Testing Market Analysis and Forecast, by Type of Assay

8. Global C-reactive Protein Testing Market Analysis and Forecasts, by Indication

9. Global C-reactive Protein Testing Market Analysis and Forecast, by End-user

10. Global C-reactive Protein Testing Market Analysis and Forecast, by Region

11. North America C-reactive Protein Testing Market Analysis and Forecast

12. Europe C-reactive Protein Testing Market Analysis and Forecast

13. Asia Pacific C-reactive Protein Testing Market Analysis and Forecast

14. Latin America C-reactive Protein Testing Market Analysis and Forecast

15. Middle East & Africa C-reactive Protein Testing Market Analysis and Forecast

16. Competition Landscape

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：検査タイプ別

第7章世界市場の分析と予測：アッセイタイプ別

第8章世界市場の分析と予測：指標別

第9章世界市場の分析と予測：エンドユーザー別

第10章世界市場の分析と予測：地域別

第11章北米市場の分析と予測

第12章欧州市場の分析と予測

第13章アジア太平洋市場の分析と予測

第14章ラテンアメリカ市場の分析と予測

第15章中東およびアフリカ市場の分析と予測

第16章競合情勢